Efficacy of odanacatib in postmenopausal women with osteoporosis: subgroup analyses of data from the phase 3 long-term odanacatib fracture trial (LOFT)

2016 ◽  
Author(s):  
Kenneth G Saag ◽  
Peter Alexandersen ◽  
Claude-Laurent Benhamou ◽  
Nigel Gilchrist ◽  
Johan Halse ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Phase 3 ◽  
Subgroup Analyses

Incidence of Hip and Subtrochanteric/Femoral Shaft Fractures in Postmenopausal Women with Osteoporosis in the Phase 3 Long‐Term Odanacatib Fracture Trial

2021 ◽  
Author(s):  
Socrates Papapoulos ◽  
Henry Bone ◽  
Felicia Cosman ◽  
David W. Dempster ◽  
Michael R. McClung ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Femoral Shaft ◽  
Phase 3 ◽  
Femoral Shaft Fractures ◽  
Shaft Fractures

Effect of odanacatib on bone density and estimated bone strength in postmenopausal women: a CT-based sub-study of the phase 3 long-term odanacatib fracture trial (LOFT)

2016 ◽  
Author(s):  
Bente Langdahl ◽  
Villiers Tobias De ◽  
Tony M Keaveny ◽  
Klaus Engelke ◽  
Harry Genant ◽  
...  
Keyword(s):  
Bone Density ◽  
Postmenopausal Women ◽  
Bone Strength ◽  
Phase 3

Effects of Odanacatib on Bone Structure and Quality in Postmenopausal Women With Osteoporosis: 5‐Year Data From the Phase 3 Long‐Term Odanacatib Fracture Trial (LOFT) and its Extension

2020 ◽  
Vol 35 (7) ◽  
pp. 1289-1299
Author(s):  
Robert Recker ◽  
David Dempster ◽  
Bente Langdahl ◽  
Hilde Giezek ◽  
Seth Clark ◽  
...  
Keyword(s):  
Postmenopausal Women ◽  
Bone Structure ◽  
Phase 3
Sign in / Sign up

Export Citation Format

Share Document